OTC: NVYTF - Novacyt S.A.

Yield per half year: -14.99%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Novacyt S.A.


About Novacyt S.A.

Novacyt S.A., together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International segments. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases.

more details
The Lab21 Products segment develops, manufactures, and distributes a range of protein-based infectious disease in-vitro diagnostic device (IVD) products. The IT-IS International segment develops and manufactures PCR devices for the life sciences and food testing industry. The company was incorporated in 2006 and is based in Vélizy-Villacoublay, France.

Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета gbp
Сайт https://www.novacyt.com
Цена ао 0.641
Change price per day: -0% (0.641)
Change price per week: -0% (0.641)
Change price per month: -0% (0.641)
Change price per 3 month: +2.23% (0.627)
Change price per half year: -14.99% (0.754)
Change price per year: +28.2% (0.5)
Change price per 3 year: -79.46% (3.12)
Change price per 5 year: -54.21% (1.4)
Change price per year to date: +13.25% (0.566)

Underestimation

Title Value Grade
P/S 3.46 5
P/BV 0.4577 10
P/E 0 0
EV/EBITDA -0.6981 0
Total: 5.63

Efficiency

Title Value Grade
ROA, % -21.07 0
ROE, % -32.31 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.999 10
Total: 9

Growth impulse

Title Value Grade
Yield Revenue, % 3.61 1
Yield Ebitda, % 1185.58 10
Yield EPS, % -261.79 0
Total: 6.2

Institutions Volume Share, %
Legato Capital Management LLC 13390 0.02



Head Job title Payment Year of birth
Bryan Close Chief Operations Officer N/A
Mr. Lyn Dafydd Rees CEO & Executive Director N/A 1973 (52 years)
Mr. Steve Gibson CFO & Director N/A
Dr. Joanne Mason Chief Scientific Officer & Director 1975 (50 years)
Mr. David Franks Chief Human Resources Officer
Paul Oladimeji Group Head of R&D

Address: United Kingdom, Eastleigh, York House - open in Google maps, open in Yandex maps
Website: https://www.novacyt.com